Prevalence of Molecular Mutations in Non–Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion

专家意见 肺癌 癌症 医学 电流(流体) 系统回顾 肿瘤科 政治学 梅德林 重症监护医学 内科学 工程类 电气工程 法学
作者
Abdulaziz AlJassim,Aladdin Kanbour,Fathi Azribi,Muath Al-Nassar,Riadh Mohsen,Sahar Dawod,Selvaraj Giri,Michael Nasr Kamal,Ali AlJabban,Layth Mula‐Hussain,Bader Alshamsan,Emad Anwar
出处
期刊:Journal of immunotherapy and precision oncology [Innovative Healthcare Institute]
卷期号:8 (3): 233-241 被引量:2
标识
DOI:10.36401/jipo-24-35
摘要

Over the past decade, the discovery of immunotherapy and targeted therapy has set new standards for the management of advanced non–small cell lung cancer (NSCLC). This study aims to investigate the prevalence of ALK , EGFR , KRAS , ROS1 , MET , BRAF , and HER2 mutations in patients with NSCLC within the Middle East and North Africa (MENA) region and to assess the current state of molecular testing and targeted treatments in the Gulf Cooperation Council (GCC) region. The systematic literature review was performed using PubMed, Google Scholar, and Google searches to identify studies on the prevalence of ALK , EGFR , KRAS , ROS1 , MET , BRAF , and HER2 mutations in patients with NSCLC in the MENA region. Additionally, 10 experts from the GCC region were interviewed to provide insights into molecular mutation testing, the challenges faced, and the current approaches to targeted therapies. The prevalence of ALK , EGFR , KRAS , ROS1 , MET , and BRAF mutations was 7.9% (95% CI, 6.69–9.03%), 24% (95% CI, 22.05–25.41%), 19.7% (95% CI, 15.29–24.07%), 2.2% (95% CI, 0.77–3.57%), 4.7% (95% CI, 2.29–7.07%) and 3.7% (95% CI, 1.54–5.80%), respectively. HER2 mutation data were unavailable. Treatment generally adhered to international guidelines, with therapy selection based on tumor stage, molecular profile, and drug availability. Expert opinions highlighted significant advancements in molecular diagnostics and targeted therapies but also pointed out the challenges in standardizing and implementing these techniques across the GCC region. This review underscores the importance of personalized and region-specific approaches to NSCLC treatment, given the significant differences in mutation patterns in the MENA region. Further research is needed to gain a more comprehensive understanding of the prevalence and effect of driver mutations across broader MENA countries to inform future treatment strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
279完成签到,获得积分10
刚刚
刚刚
赘婿的应助被超级盼烟采纳,获得10
1秒前
共享精神的应助被舒适沛蓝采纳,获得10
2秒前
3秒前
wg发布了新的文献求助10
3秒前
4秒前
molihuakai的应助被科研通管家采纳,获得10
4秒前
所所的应助被科研通管家采纳,获得10
4秒前
汉堡包的应助被科研通管家采纳,获得10
5秒前
小二郎的应助被科研通管家采纳,获得10
5秒前
爆米花的应助被kui采纳,获得10
5秒前
5秒前
syvshc的应助被科研通管家采纳,获得10
5秒前
田様的应助被科研通管家采纳,获得10
5秒前
Nole的应助被tib采纳,获得10
5秒前
小二郎的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
天天快乐的应助被科研通管家采纳,获得10
5秒前
6秒前
6秒前
大模型的应助被科研通管家采纳,获得10
6秒前
6秒前
syvshc的应助被科研通管家采纳,获得10
6秒前
英姑的应助被幸运周周周采纳,获得10
6秒前
早上好完成签到,获得积分10
7秒前
7秒前
Lixin发布了新的文献求助10
8秒前
8秒前
阳佟水蓉发布了新的文献求助10
9秒前
浩想椰汁完成签到,获得积分20
9秒前
Voskov完成签到,获得积分10
10秒前
TCMning发布了新的文献求助10
10秒前
11秒前
11秒前
1111111发布了新的文献求助10
11秒前
12秒前
浩想椰汁发布了新的文献求助30
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188394
求助须知:如何正确求助?哪些是违规求助? 9576268
关于积分的说明 21846207
捐赠科研通 7786486
什么是DOI,文献DOI怎么找? 3435317
关于科研通互助平台的介绍 2559618
邀请新用户注册赠送积分活动 2482322